A new vaccine is offering hope for people fighting an aggressive form of breast cancer. Dr. Michael Daignault talks about this vaccine as well as other medical news.

A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.

A new therapeutic vaccine offers fresh hope for women battling super aggressive triple-negative cancer. The vaccine teaches patients’ immune systems to identify and attack cancer cells. Around 16 out of 18 patients remained cancer-free three years after receiving the vaccine.

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a new vaccine that is preventing cancer from returning.

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St.

New research suggests an experimental vaccine could provide new hope for women diagnosed with an aggressive, hard-to-treat form of breast cancer. This vaccine is effective against triple-negative breast cancer,

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive results in a clinical trial.